Is Ares CRE ACRE stock a strong investment pick Q4 2025 EPS Misses Views Vertex Pharmaceuticals VRTX Poised for Material Upside as Lead IgA Nephropathy Asset Rides FastExpanding Rare Kidney Disease Market PRHI Presurance Holdings posts surprise Q1 2024 profit shares gain on upbeat investor reaction to strong performance GTX Garrett Motion Q1 2026 EPS beats estimates by nearly 15 percent sending shares up almost 25 percent in one trading day Centessa CNTA Stock Investment Risks Quiet 20260427 BSBK Bogota FinCo posts Q1 2025 EPS of 006 slips 053 as investors digest lack of performance forecasts Is Stem STEM stock testing support today Stem logs 24 EPS beat narrower loss tops estimates Oshkosh OSK Stock Valuation Analysis Oshkosh reports 32 EPS miss falling short of analyst estimates